Saba could extinguish Baillie Gifford US Growth Trust if shareholders do not vote against it at an upcoming AGM ...

OXB (OXB), formerly Oxford BioMedica, enjoyed a steady first half after the contract medicines manufacturer reported a 9 per ...

Midwich saw a working capital outflow of £23.9mn during the period – a partial consequence of seasonality of demand, ...

Although some demand remains lumpy, recurring revenues are starting to dominate this logistics supplier’s top line ...

In recent years, this momentum style has been dominant and earlier this summer, famed stock picker and Fundsmith founder ...

That, along with other one-off costs from the restructuring, meant M&C swung to a £161,000 pre-tax loss in the first half. Margins were already squeezed by spending to scale up businesses including ...

As a result, the FTSE 100 is down 0.2 per cent this morning, and shares in Paris and Frankfurt have fallen 0.15 and 0.4 per ...

Target Healthcare Reit (THRL) likes to position itself as “stable and boring”, in the words of lead fund manager Kenneth MacKenzie, chief executive of Target’s investment manager.

Still, the number of Mortgage Advice Bureau’s advisers increased by 9 per cent during the period, and revenue per adviser was ...

PureTech will fund a slice of the trials via its equity stake, rather than direct spend, while retaining a long-term royalty interest of 1–3 per cent. In other words, the development risks have been ...

Healthcare diagnostics software platform Diaceutics (DXRX) appears to have hit an inflection point in its growth. Diaceutics’ DXRX data platform provides ‘clinical intent signals’ to drug ...

For a stock to justify punchy ratings, ROCI and profits need to be high and rising. That should be because the business is growing organically - preferably selling more units and not just ramping up ...